CommercialCoverageMedium impact
Ovarian and Internal Iliac Vein Endovascular Occlusion as a Treatment of Pelvic Congestion Syndrome 4.01.10
Excellus BlueCross BlueShield·OB-GYN, Vascular Surgery, Radiology·Women's Health (Obstetrics & Gynecology)
Effective date
Sep 18, 2025
We identified it
Jun 20, 2026
Summary
Excellus BlueCross BlueShield has classified endovascular occlusion of ovarian and internal iliac veins for treating pelvic congestion syndrome as investigational and not medically proven effective. This means the procedure will not be covered and claims will be denied for this indication.
Action Required
By September 18, 2025: Billing team must update systems to flag endovascular occlusion procedures (coil embolization, sclerotherapy, vascular plug procedures) for pelvic congestion syndrome as non-covered for Excellus BlueCross BlueShield. Notify ob-gyn and interventional radiology providers that these procedures are considered investigational. Claims will be denied without coverage determination.